23 July 2024 Third Arc Bio Launches with Oversubscribed $165 Million Series A Financing to Deliver Superior Biologics for Solid Tumors and Inflammatory & Immunology (I&I) Diseases read more
16 July 2024 Scorpion Therapeutics Announces $150 Million Series C Financing to Advance Leading Clinical-stage Precision Oncology Pipeline read more
21 May 2024 Aktis Oncology enters into Strategic Collaboration with Lily to Discover and Develop Novel Anticancer Radiopharmaceuticals read more
26 March 2024 Tectonic Therapeutic Initiates Phase 1B Study for TX45 in Group 2 Pulmonary Hypertension in Patients with Preserved Ejection Fraction Heart Failure read more
